908 Devices Inc.
For the period ended Dec 31, 2025. Filed Mar 9, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 9, 2026
MASS$9.99-13.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Stockholders’ Equity
(in thousands, except share amounts)
| | | | | | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| · · · · · · · · · Accumulated · · · · · · | ||||||||||||||||
| · · · Additional · · Other · · · · Total | ||||||||||||||||
| · Common Stock · · Paid-in · · Comprehensive · · Accumulated · · Stockholders' | ||||||||||||||||
| · Shares · · Amount · · Capital · · Income · · Deficit · · Equity | ||||||||||||||||
| Balances at December 31, 2023 | 32,519,023 | | $33 | | $334,692 | | $1,365 | | $(170,599) | | $165,491 | |||||
| Issuance of common stock upon exercise of stock options | 347,483 | | | — | | | 570 | | | — | | | — | | | 570 |
| Stock-based compensation expense | — | | | — | | | 11,763 | | | — | | | — | | | 11,763 |
| Issuance of common stock pursuant to the acquisition of RedWave Technology | 1,497,171 | | | 2 | | | 8,615 | | | — | | | — | | | 8,617 |
| Issuance of common stock upon ESPP purchase | 161,345 | | | — | | | 576 | | | — | | | — | | | 576 |
| Vesting of restricted stock units | 573,471 | | | — | | | — | | | — | | | — | | | — |
| Foreign currency translation adjustments | — | | | — | | | — | | | (219) | | | — | | | (219) |
| Net loss | — | | | — | | | — | | | — | | | (72,206) | | | (72,206) |
| Balances at December 31, 2024 | 35,098,493 | | $35 | | $356,216 | | $1,146 | | $(242,805) | | $114,592 | |||||
| Issuance of common stock upon exercise of stock options | 228,404 | | | — | | | 481 | | | — | | | — | | | 481 |
| Stock-based compensation expense | — | | | — | | | 9,845 | | | — | | | — | | | 9,845 |
| Issuance of common stock upon ESPP purchase | 104,804 | | | — | | | 384 | | | — | | | — | | | 384 |
| Vesting of restricted stock units | 890,165 | | | 1 | | | (1) | | | — | | | — | | | — |
| Foreign currency translation adjustments | — | | | — | | | — | | | (7) | | | — | | | (7) |
| Foreign currency translation adjustments reclassed out of accumulated other comprehensive income related to discontinued operations | — | | | — | | | — | | | (1,125) | | | — | | | (1,125) |
| Unrealized gain on marketable securities | — | | | — | | | — | | | 40 | | | — | | | 40 |
| Net income | — | | | — | | | — | | | — | | | 19,489 | | | 19,489 |
| Balances at December 31, 2025 | 36,321,866 | | $36 | | $366,925 | | $54 | | $(223,316) | | $143,699 | |||||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.